SEATTLE – When considering an adaptive trial design proposal, FDA wants to see simulation studies that consider different scenarios for the variable components of the alternative clinical trial as support for the experimental protocol.
“It’s always necessary to conduct” a simulation study to support an adaptive design, Sue Jane Wang, associate director of adaptive...